Q
Quant'AbondanceL'abondance, quantifiée.

Actualités

Uniquement les titres à fort signal - événements macro, résultats, M&A, régulation. Listicles et clickbait d'analystes filtrés par défaut. Rafraîchi toutes les heures.

24,463 signal articles · 160 in last 24h · 116,475 total before filter · latest 1h ago
160last 24h
1718last 7d
283● bullish (7d)
154● bearish (7d)
205publishers
AllMacro319Earnings779M&A102Regulatory24Product16Analyst23
✕ clear all filterssentiment: bullishSentiment:bullishneutralbearishshow all (incl. clickbait)
Robinhood Earnings Due. Here Is What To Watch And Expect.
Investor's Business Daily19d agobullish
Robinhood Earnings Due. Here Is What To Watch And Expect.

Robinhood earnings are due late Wednesday, with Coinbase earnings following on Thursday, as brokerage industry rivalries intensify. Coinbase is on deck late Thursday. Robinhood, which has offered cryptocurrency trading since 2018, continues to expand in that market, both in the U.S. and internationally.

Investing.com19d agobullish
L’Oréal shares jump after strong Q2 beat and record margin

Investing.com -- Shares of L’Oréal SA jumped over 4% on Thursday, a day after the world’s largest beauty group reported second-quarter organic sales growth that beat both consensus and BofA Securities’ estimates, alongside a record first-half operating margin.

Bloomberg19d agobullish
Wall Street Picks AI Winners and Losers as Credit Swaps Surge

(Bloomberg) -- As Big Tech barrels toward trillions of dollars of planned spending on AI, a key cog in credit markets is showing signs of pressure. That, in turn, is lifting the cost of financing artificial intelligence while offering an early look at potential winners and losers.Most Read from BloombergUS Intercepts Iran Attack on Bases, Puncturing Days of CalmSK Hynix Profit Disappoints, Spending Soars to $31 BillionApple Set to Make Big Smart Home Push With Siri AI at CenterNvidia’s $750 Bill

Teradyne Stock Jumps as Earnings Guidance Does the Seemingly Impossible—Impresses Wall Street
Barrons.com19d agobullish
Teradyne Stock Jumps as Earnings Guidance Does the Seemingly Impossible—Impresses Wall Street

It takes a lot for artificial-intelligence trade-related companies to impress Wall Street with earnings or guidance these days, but Teradyne has done just that. Shares of the semiconductor test equipment manufacturer rose 9% to $338.43 on Wednesday after the company late Tuesday reported better-than-expected second-quarter earnings and solid quarterly guidance. Teradyne posted adjusted earnings of $2.47 a share in the second quarter, up from 57 cents a year ago and well above Wall Street’s expectation of $2.09.

Medicare Drug Plan Premiums Are About to Jump for 25 Million Seniors
Barrons.com19d agobullish
Medicare Drug Plan Premiums Are About to Jump for 25 Million Seniors

Medicare beneficiaries may face higher premiums next year for their Part D drug plans, as the federal government plans to end subsidies that helped mitigate price increases in the program. The Trump administration will not continue the subsidies beyond 2026, The Wall Street Journal reported. About 25 million Medicare recipients are enrolled in a stand-alone Part D plan for their drug coverage.

Qualcomm wins BMW chip supply deal for future vehicle platforms
Reuters19d agobullish
Qualcomm wins BMW chip supply deal for future vehicle platforms

Qualcomm said on Wednesday it has signed a long-term deal to supply ‌chips for German luxury automaker BMW's future ‌digital cockpit and advanced driver-assistance systems through the next decade. The ​agreement comes as competition intensifies in the automated driving market, with Nvidia and Mobileye Global also aiming to supply chips and software platforms to automakers. • The ‌deal includes Qualcomm's ⁠Snapdragon Digital Chassis solutions, including cockpit processors, automated driving chips and AI accelerators, which ⁠the companies said would establish the hardware basis for BMW's AI-led platforms.

Investing.com19d agobullish
Is the AI rally running out of steam?

Investing.com -- Capital Economics told clients in a note Wednesday that the recent selloff in AI-linked tech giants is being driven by fear rather than hard evidence, and it expects the rally to resume, at least for now.